Organogenesis Holdings Inc. (ORGO): Free Cash Flow
-$24.46M
Year ended 2025-12-31
$20.84M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$24.46M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $4.18M | -36.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $6.55M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$9.04M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $30.76M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$12.21M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$39.51M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$62.49M | n/m | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | -$5.92M | n/c | 2020-03-09, From 2017-01-01 |
| 2016-12-31 | -$6.23M | n/a | 2019-03-18, From 2016-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | -$24.46M | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | -$78.81M | n/m |
| Insmed Inc (INSM) | 2025-12-31 | -$967.58M | n/m |
| Opko Health, Inc. (OPK) | 2025-12-31 | -$190.82M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $54.87M | +488.0% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | -$24.99M | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$447.01M | n/m |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | -$93.89M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $28.84M | +101.3% |
Compare ORGO, HCM, INSM, OPK side by side · Screen every company in Pharmaceutical Preparations ↗